The results of the Diabetes Control and Complications Trial (DCCT) showed an outstanding benefit of almost 70 percent reduction in microvascular disease when driving down A1C to 7, but also showed a higher frequency of hypoglycemia -- events that patients don’t forget. "It was clear intensive therapy back then came with a significant price."

Listen now to the 9-minute podcast with Dr. Jack Leahy and Dr. Doron Schneider: DCCT and EDIC: Impact of Tight Control on Hypoglycemia